Safety, Tolerability, and Preliminary Efficacy of TAR-200 inPatients With Muscle-invasive Bladder Cancer Who Refused orWere Unfit for Curative-intent Therapy: A Phase 1 Study Reply
JOURNAL OF UROLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要